Implementation Stays Higher Amid Drug Makers in the RFID in Pharmaceuticals Market

The market for radio-frequency identification (RFID) in pharmaceuticals was estimated at more than US$ 950 Million during 2018 and is likely to record a Y-o-Y growth at around 10% during 2019. Prospects stay noteworthy for the RFID in the pharmaceuticals sector, as competence-led actions of participants keep on enhancing the accuracy and reliability of their business operations.

The growing need for proficient supply chain management will help the development of the worldwide market for RFID in pharmaceuticals over the years to come. RFID labels and tags are utilized to store detailed data around 2 KB identified with the item on which they are labeled. With RFID labels and tags, the costs and details of items are automatically recorded when a consumer advances the counter, with no scanning every single product, which spares the customer’s time. In addition, it permits cost count in one scan that saves the time of utilization. These benefits have urged pharmaceutical organizations to embrace RFID labels and tags for labeling their items.

A few organizations in the worldwide pharmaceutical sector are incorporating the IoT (Internet of Things) technology to oversee and encourage the high stage of value confirmation necessitated with the end goal of pharmaceutical production. For example, Pfizer Inc. has integrated the utilization of RFID labeling to handle the issue of forging. In addition, consolidating the IoT technology with public education and awareness essentially builds information results and compliance. Different organizations have begun offering drug bottles that keep customers and patients communicated concerning when they were previously opened. Remotely useable smart pills are probably going to extend all through the environment in the coming years.

Download a Sample Report with Table of Contents and Figures:

Key Takeaways from Market Research

  • Sales of chipless RFID would remain more than 2X that of the chipped RFID during 2019.
  • Benefits in the market would stay complemented by RFID tags sales, with revenues during 2018 holding more than one-third market share.
  • Adoption will foresee higher-development amid hospitals and clinics and drug wholesalers, which jointly hold more than the two-fifth share of the market.
  • North America would stay the foremost market, trailed by Europe. The supremacy of emerged economies in the worldwide market is considerably ascribed to strict regulations & standards carried out for serialization, and relative greater occurrence of generic drugs and OTC in these regions.

The worldwide market reflects a consolidated competition scenario; wherein foremost organizations hold a market revenue share of over 55%. The majority of the players in the market are deliberately concentrating on the APEJ and North America region. A few of the RFID technology suppliers for pharmaceutical organizations are concentrating on new developments and technological progressions in their items. This encourages it to upgrade its market share and extend its product contributions to different industry verticals.

In any case, challenges identified with regulatory rule wording, execution of two-dimensional barcode innovation, along with the assortment of interfaces inside the pharmaceutical supply chain have deferred implementation and its full usage.

For information on the research approach used in the report, request methodology@

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

Mr. Abhishek Budholiya
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790

Leave a comment

Your email address will not be published. Required fields are marked *